[Evolution and thromboembolic complications of the idiopathic peripartal cardiomyopathy at Dakar University Hospital:

Ad Kane1, M Mbaye, M B Ndiaye

  • 1Clinique cardiologique, université Cheikhe-Anta-Diop, CHU Aristide-Le-Dantec, BP 21448 Ponty, Dakar, Sénégal. damskane@hotmail.com

Insights

Idiopathic myocardiopathy of the peripartum (IMPP) is common in the Soudano-Sahelian region. Early diagnosis and treatment of thrombosis and spontaneous contrast improve patient outcomes.

Area of Science:

  • Cardiology
  • Obstetrics
  • Internal Medicine

Background:

  • Idiopathic myocardiopathy of the peripartum (IMPP) is a serious condition affecting women in late pregnancy or postpartum.
  • Thrombosis and spontaneous contrast are potential complications of IMPP, necessitating further investigation.

Purpose of the Study:

  • To investigate the characteristics of IMPP.
  • To determine the prevalence and evolution of thrombosis and spontaneous contrast in IMPP patients.
  • To assess the effectiveness of diagnostic tools and treatment strategies.

Main Methods:

  • A longitudinal exploratory study was conducted from January 2001 to November 2004 at Aristide-Le-Dantec teaching hospital, Dakar.
  • The study included 33 patients diagnosed with IMPP.
  • Transthoracic echocardiography (ETT) and transesophageal echocardiography (ETO) were used to assess cardiac function and detect thrombi and spontaneous contrast.

Main Results:

  • The average patient age was 26 years, with an average of 3.39 pregnancies.
  • Cardiac insufficiency signs were present in all patients; 12% experienced ischemic cerebral vascular accidents.
  • ETT revealed thrombi in 30.3% and spontaneous contrast in 6% of patients. ETO demonstrated higher sensitivity (100%) for spontaneous contrast detection compared to ETT (66%).

Conclusions:

  • IMPP is a relatively frequent condition in the Soudano-Sahelian region, with a high occurrence of thromboses.
  • Transesophageal echocardiography is superior to transthoracic echocardiography for detecting intracardiac spontaneous contrast.
  • Favorable outcomes are achievable with rigorous care and regular surveillance, including anticoagulant therapy.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...